A framework for falsifiable explanations of machine learning models with an application in computational pathology.

Journal: Medical image analysis
Published Date:

Abstract

In recent years, deep learning has been the key driver of breakthrough developments in computational pathology and other image based approaches that support medical diagnosis and treatment. The underlying neural networks as inherent black boxes lack transparency and are often accompanied by approaches to explain their output. However, formally defining explainability has been a notorious unsolved riddle. Here, we introduce a hypothesis-based framework for falsifiable explanations of machine learning models. A falsifiable explanation is a hypothesis that connects an intermediate space induced by the model with the sample from which the data originate. We instantiate this framework in a computational pathology setting using hyperspectral infrared microscopy. The intermediate space is an activation map, which is trained with an inductive bias to localize tumor. An explanation is constituted by hypothesizing that activation corresponds to tumor and associated structures, which we validate by histological staining as an independent secondary experiment.

Authors

  • David Schuhmacher
    Ruhr-University Bochum, Center for Protein Diagnostics, Bochum, 44801, Germany; Ruhr-University Bochum, Faculty of Biology and Biotechnology, Bioinformatics Group, 44801 Bochum, Germany. Electronic address: david.schuhmacher@rub.de.
  • Stephanie Schörner
    Ruhr-University Bochum, Center for Protein Diagnostics, Bochum, 44801, Germany; Ruhr-University Bochum, Faculty of Biology and Biotechnology, Department of Biophysics, 44801 Bochum, Germany. Electronic address: stephanie.schoerner@rub.de.
  • Claus Küpper
    Center for Protein Diagnostics (ProDi), 44801 Bochum, Germany.
  • Frederik Großerueschkamp
    Center for Protein Diagnostics (ProDi), 44801 Bochum, Germany.
  • Carlo Sternemann
    Ruhr-University Bochum, Center for Protein Diagnostics, Bochum, 44801, Germany; Institute of Pathology, Ruhr-University Bochum, 44789 Bochum, Germany. Electronic address: carlo.sternemann@pathologie-bochum.de.
  • Celine Lugnier
    Ruhr-University Bochum, Center for Protein Diagnostics, Bochum, 44801, Germany; Department of Hematology, Oncology and Palliative Care, Ruhr-University Bochum, St. Josef-Hospital, 44791 Bochum, Germany. Electronic address: Celine.Lugnier@rub.de.
  • Anna-Lena Kraeft
    Ruhr-University Bochum, Center for Protein Diagnostics, Bochum, 44801, Germany; Department of Hematology, Oncology and Palliative Care, Ruhr-University Bochum, St. Josef-Hospital, 44791 Bochum, Germany. Electronic address: al.kraeft@gmail.com.
  • Hendrik Jütte
    Ruhr-University Bochum, Center for Protein Diagnostics, Bochum, 44801, Germany; Institute of Pathology, Ruhr-University Bochum, 44789 Bochum, Germany. Electronic address: hendrik.juette@rub.de.
  • Andrea Tannapfel
    Ruhr-University Bochum, Center for Protein Diagnostics, Bochum, 44801, Germany; Institute of Pathology, Ruhr-University Bochum, 44789 Bochum, Germany. Electronic address: andrea.tannapfel@pathologie-bochum.de.
  • Anke Reinacher-Schick
    Ruhr-University Bochum, Center for Protein Diagnostics, Bochum, 44801, Germany; Department of Hematology, Oncology and Palliative Care, Ruhr-University Bochum, St. Josef-Hospital, 44791 Bochum, Germany. Electronic address: anke.reinacher@rub.de.
  • Klaus Gerwert
    Department of Biophysics, Ruhr-University Bochum, Bochum, Germany.
  • Axel Mosig
    Department of Biophysics, Ruhr-University Bochum, Bochum, Germany.